Melanie Bahlo

Melanie Bahlo

BSc (Honours), PhD, AM

Neurologist

28+ years of Experience

Female📍 Parkville

About of Melanie Bahlo

Melanie Bahlo is a neurologist based in Parkville, NSW 3052. She works with people across a wide range of nervous system conditions, from seizures and epilepsy to movement and nerve problems. Neurology can be overwhelming, especially when symptoms are new or come and go. Melanie takes a calm, practical approach, focusing on what is happening now and what may be going on underneath.


Over time, her work has covered both common and rare diagnoses. Many patients see her for epilepsy, including genetic forms and seizure types that start in childhood. She also looks after people with at times hard to control seizures, myoclonus (sudden jerks), and conditions where night-time episodes are a big part of daily life. In many cases, these problems are linked with inherited changes, so she helps patients and families make sense of genetic results and next steps.


Melanie also supports people with movement disorders and other neurological issues. This can include problems with coordination, such as hereditary ataxia, and ongoing nerve symptoms like peripheral neuropathy. At times, patients may be dealing with progressive conditions too, including motor neuron disease such as ALS. She understands that these journeys can be long, and plans are often built step by step as the situation changes.


She has more than 28 years of experience. That matters, because neurology often needs careful thinking and steady follow-up, not rushed decisions. Melanie’s background helps her balance day-to-day symptom care with longer-term planning, especially when the cause is genetic or when more than one body system is involved.


Melanie’s education includes a BSc (Honours) from Monash University (1992). She later completed a PhD in population genetics and statistics at Monash University (1997). She also holds an AM. That research training is useful when it comes to understanding patterns in inherited conditions and making sense of how genetic information can guide care.


People usually come in wanting clear answers, and sometimes they just want reassurance that they are not alone. Melanie aims to keep appointments down to what is useful: explaining options in everyday terms, talking through risks and benefits, and helping patients work out a plan that fits their lives.

Education

  • BSc (Honours) - Bachelor of Science (Honours); Monash University, Australia; 1992
  • PhD - Doctor of Philosophy in Population Genetics / Statistics; Monash University, Australia; 1997

Services & Conditions Treated

Myoclonic EpilepsyAutosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)Drug Induced DyskinesiaEpilepsyEpilepsy with Myoclonic-Atonic SeizuresMosaicismPartial Familial EpilepsySpondylocarpotarsal Synostosis SyndromeAcute Cerebellar AtaxiaAmyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)ApraxiaCoats DiseaseCortical DysplasiaDentatorubral-Pallidoluysian AtrophyDysarthriaEpilepsy in ChildrenGenetic Epilepsy with Febrile Seizures Plus (GEFS+)Hereditary AtaxiaHereditary Sensory Neuropathy Type 1 (HSN1)Lafora DiseaseLissencephalyLissencephaly 1Miller-Dieker SyndromeOlivopontocerebellar AtrophyPeriventricular HeterotopiaPhotosensitive EpilepsyPrimary Lateral SclerosisSeizuresSpinocerebellar AtaxiaSpinocerebellar Ataxia Type 4Spinocerebellar Ataxia Type 5Subcortical Band HeterotopiaTelangiectasiaThin Basement Membrane NephropathyWest SyndromeWinchester SyndromeAbsence SeizureAchalasia Microcephaly SyndromeAcute Intermittent PorphyriaAge-Related Macular Degeneration (ARMD)AnhidrosisAutism Spectrum DisorderBatten DiseaseBilateral Perisylvian PolymicrogyriaCardiomyopathyChronic Recurrent Multifocal OsteomyelitisCLN1 DiseaseCLN2 DiseaseCLN3 DiseaseCLN4 DiseaseCLN5 DiseaseCommon Variable Immune DeficiencyCongenital Fiber-Type DisproportionCorpus Callosum AgenesisCramp-Fasciculation SyndromeDeafness Craniofacial SyndromeDementiaDiabetic RetinopathyEncephaloceleEpilepsy Juvenile AbsenceFamilial DysautonomiaFriedreich AtaxiaFrontotemporal DementiaGangliogliomaGangliosidosisGeneralized Tonic-Clonic SeizureGM1 GangliosidosisHajdu-Cheney SyndromeHallervorden-Spatz DiseaseHearing LossHereditary Sensory and Autonomic Neuropathy Type 2Hydrocephalus due to Congenital Stenosis of Aqueduct of SylviusHypertrophic Cardiomyopathy (HCM)HypogonadismHypothalamic HamartomasHypothermiaHypotoniaInfant Hearing LossIntersexJuvenile Myoclonic EpilepsyKnobloch SyndromeL1 SyndromeLate-Onset Retinal DegenerationLeigh SyndromeLennox-Gastaut Syndrome (LGS)MalariaMicrocephalyMitochondrial Complex 1 DeficiencyMovement DisordersMyoclonus-DystoniaMyotonic DystrophyMyotonic Dystrophy Type 2Nonsyndromic Hearing LossOsteolysis Syndrome RecessiveParamyotonia CongenitaParkinson's DiseasePeripheral NeuropathyPolydactylyPolymicrogyriaPontocerebellar HypoplasiaPorphyriaProtein DeficiencyScabiesSpasmus NutansSpastic Paraplegia Type 11Spastic Paraplegia Type 2Spastic Paraplegia Type 7Spinocerebellar Ataxia Type 8Spinocerebellar Degeneration and Corneal DystrophyStriatonigral Degeneration InfantileTubular Aggregate MyopathyTurner SyndromeType 2 Diabetes (T2D)Ventricular FibrillationX-Linked Myotubular Myopathy

Publications

5 total
Identifying individuals with rare disease variants by inferring shared ancestral haplotypes from SNP array data.

NAR genomics and bioinformatics • November 20, 2024

Erandee Robertson, Bronwyn Grinton, Karen Oliver, Liam Fearnley, Michael Hildebrand, Lynette Sadleir, Ingrid Scheffer, Samuel Berkovic, Mark Bennett, Melanie Bahlo

We describe FoundHaplo, an identity-by-descent algorithm that can be used to screen untyped disease-causing variants using single nucleotide polymorphism (SNP) array data. FoundHaplo leverages knowledge of shared disease haplotypes for inherited variants to identify those who share the disease haplotype and are, therefore, likely to carry the rare [minor allele frequency (MAF) ≤ 0.01%] variant. We performed a simulation study to evaluate the performance of FoundHaplo across 33 disease-harbouring loci. FoundHaplo was used to infer the presence of two rare (MAF ≤ 0.01%) pathogenic variants, SCN1B c.363C>G (p.Cys121Trp) and WWOX c.49G>A (p.E17K), which can cause mild dominant and severe recessive epilepsy, respectively, in the Epi25 cohort and the UK Biobank. FoundHaplo demonstrated substantially better sensitivity at inferring the presence of these rare variants than existing genome-wide imputation. FoundHaplo is a valuable screening tool for searching disease-causing variants with known founder effects using only SNP genotyping data. It is also applicable to nonhuman applications and nondisease-causing traits, including rare-variant drivers of quantitative traits. The FoundHaplo algorithm is available at https://github.com/bahlolab/FoundHaplo (DOI:10.5281/zenodo.8058286).

Understanding Plasmodium vivax recurrent infections using an amplicon deep sequencing assay, PvAmpSeq, identity-by-descent and model-based classification.

MedRxiv : The Preprint Server For Health Sciences • June 10, 2025

Jason Rosado, Jiru Han, Thomas Obadia, Jacob Munro, Zeinabou Traore, Kael Schoffer, Jessica Brewster, Caitlin Bourke, Joseph Vinetz, Michael White, Melanie Bahlo, Dionicia Gamboa, Ivo Mueller, Shazia Ruybal Pesántez

Plasmodium vivax infections are characterised by recurrent bouts of blood-stage parasitaemia. Understanding the genetic relatedness of recurrences can distinguish whether these are caused by relapse, reinfection, or recrudescence, which is critical to understand treatment efficacy and transmission dynamics. We developed PvAmpseq, an amplicon sequencing assay targeting 11 SNP-rich regions of the P. vivax genome. PvAmpSeq was validated on field isolates from a clinical trial in the Solomon Islands and a longitudinal observational cohort in Peru, and statistical models were applied for genetic classification of infection pairs. In the Solomon Islands trial, where participants received antimalarials at baseline, half of the recurrent infections were caused by parasites with >50% relatedness to the baseline infection, with statistical models classifying 25% and 25% as probable relapses and recrudescences, respectively. In the Peruvian cohort, 26% of recurrences were likely relapses. PvAmpSeq provides high-resolution genotyping to characterise P. vivax recurrences, offering insights into transmission and treatment outcomes.

Comprehensive Characterisation of the RFC1 Repeat in an Australian Cohort.

Cerebellum (London, England) • June 01, 2025

Kayli Davies, Haloom Rafehi, Liam Fearnley, Penny Snell, Greta Gillies, Tess Field, Gábor Halmágyi, Kishore Kumar, Kate Pope, Renee Smyth, Susan Tomlinson, Stephen Tisch, Chi-chang Tang, Shaun R Watson, Thomas Wellings, Kathy H Wu, David Szmulewicz, Martin Delatycki, Melanie Bahlo, Paul Lockhart

RFC1-related disease, which includes cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS), is a late-onset neurodegenerative disorder primarily caused by biallelic AAGGG(n) repeat expansions (RE) in RFC1. The RFC1 locus is highly polymorphic, with multiple pathogenic and non-pathogenic repeat motifs identified. This study aimed to characterise the structure of the RFC1 repeat and determine the pathogenic allele frequency in an Australian cohort. Using a combination of PCR and next generation sequencing techniques, we provide a comprehensive characterisation of the RFC1 repeat locus in an Australian cohort of 232 individuals with adult-onset ataxia and 269 healthy controls. Biallelic pathogenic RFC1 variants were identified in 34.1% of affected individuals. The overwhelming majority (93.7%) have biallelic AAGGG(n) RE, although other pathogenic alleles, including ACAGG(n), AAAGG(>500) and the Māori AAAGG(10-25)AAGGG(n)AAAGG(4-6) configuration were detected in some affected individuals. We also demonstrate the utility of targeted long-read sequencing in resolving complex alleles. The carrier frequency of the pathogenic AAGGG(n) expansion was approximately 1 in 16 in controls, highlighting the potential for pseudodominant inheritance and the likelihood that RFC1-related disease is underdiagnosed. We further demonstrate the significant RFC1 repeat heterogeneity, identifying 16 distinct motifs, complex repeat structures, and at least six motifs with an allele frequency > 1%. The frequency of RFC1-related disease in individuals with adult-onset cerebellar ataxia and the high carrier frequency of pathogenic RFC1 alleles in the Australian population underscores the need for improved diagnostic strategies. Our findings indicate RFC1 RE are a major cause of late-onset cerebellar ataxia and sensory neuropathy in Australia and provide further insights into RFC1 repeat diversity.

GeneSetPheno: a web application for the integration, summary, and visualization of gene and variant-phenotype associations across gene sets.

Bioinformatics Advances • December 09, 2024

Jiru Han, Zachary Gerring, Longfei Wang, Melanie Bahlo

The comprehensive study of genotype-phenotype relationships requires the integration of multiple data types to "triangulate" signals and derive meaningful biological conclusions. Large-scale biobanks and public resources generate a wealth of comprehensive results, facilitating the discovery of associations between genes or genetic variants and multiple phenotypes. However, analyzing these data across resources presents several challenges, including limited flexibility in gene set analysis, the integration of multipe databases, and the need for effective data visualization to aid interpretation. GeneSetPheno is a user-friendly graphical interface that integrates, summarizes, and visualizes gene and variant-phenotype associations across genomic resources. It allows users to explore interrelationships between genetic variants and phenotypes, offering insights into the genetic factors driving phenotypic variation within user-defined gene sets. GeneSetPheno also supports comparisons across gene sets to identify shared or unique genetic variants, phenotypic associations, biological pathways, and potential gene-gene interactions. GeneSetPheno is a free and highly configurable tool for exploring the complex relationships between gene sets, genetic variants, and phenotypes. Target users include molecular biologists and clinicians who wish to explore a gene or gene set of particular interest. GeneSetPheno is freely accessible at: https://shiny.wehi.edu.au/han.ji/GeneSetPheno/. The source code is available on GitHub at: https://github.com/bahlolab/GeneSetPheno.

Genetic Risk of Reticular Pseudodrusen in Age-Related Macular Degeneration: HTRA1 /lncRNA BX842242.1 dominates, with no evidence for Complement Cascade involvement.

MedRxiv : The Preprint Server For Health Sciences • October 14, 2024

Samaneh Farashi, Carla Abbott, Brendan Ansell, Zhichao Wu, Lebriz Altay, Ella Arnon, Louis Arnould, Yelena Bagdasarova, Konstantinos Balaskas, Fred Chen, Emily Chew, Itay Chowers, Steven Clarke, Catherine Cukras, Cécile Delcourt, Marie-noëlle Delyfer, Anneke Den Hollander, Sascha Fauser, Robert Finger, Pierre-henry Gabrielle, Jiru Han, Lauren Hodgson, Ruth Hogg, Frank Holz, Carel Hoyng, Himeesh Kumar, Eleonora Lad, Aaron Lee, Ulrich Luhmann, Matthias Mauschitz, Amy Mcknight, Samuel Mclenachan, Aniket Mishra, Ismail Moghul, Luz Orozco, Danuta Sampson, Liam Scott, Vasilena Sitnilska, Scott Song, Amy Stockwell, Anand Swaroop, Jan Terheyden, Liran Tiosano, Adnan Tufail, Brian Yaspan, Robyn Guymer, Melanie Bahlo

Age-related macular degeneration (AMD) is a multifactorial retinal disease with a large genetic risk contribution. Reticular pseudodrusen (RPD) is a sub-phenotype of AMD with a high risk of progression to late vision threatening AMD. In a genome-wide association study of 2,165 AMD+/RPD+ and 4,181 AMD+/RPD-compared to 7,660 control participants, both chromosomes 1 ( CFH ) and 10 ( ARMS2/HTRA1 ) major AMD risk loci were reidentified. However association was only detected for the chromosome 10 locus when comparing AMD+/RPD+ to AMD+/RPD-cases. The chromosome 1 locus was notably absent. The chromosome 10 RPD risk region contains a long non-coding RNA (ENSG00000285955/BX842242.1) which colocalizes with genetic markers of retinal thickness. BX842242.1 has a strong retinal eQTL signal, pinpointing the parafoveal photoreceptor outer segment layer. Whole genome sequencing of phenotypically extreme RPD cases identified even stronger enrichment for the chromosome 10 risk genotype.

Frequently Asked Questions

What services does Dr Melanie Bahlo offer?
Dr Bahlo specialises in neurology with a focus on epilepsy and related movement and neurological conditions. Her listed services include evaluation and management of various epilepsies, genetic epilepsy, myoclonus-dystonia and other movement disorders, ataxias, and related symptoms such as dysarthria and cognitive involvement.
Which conditions can Dr Bahlo help with?
She has experience with a wide range of neurological and genetic conditions, including different forms of epilepsy (e.g., myoclonic, focal, generalized), autosomal dominant nocturnal frontal lobe epilepsy, spinocerebellar ataxias, hereditary neuropathies, and other listed genetic and neurological disorders.
Who can make an appointment with Dr Bahlo in Parkville?
Appointments are offered in Parkville, NSW 3052, Australia. For booking details, please contact the clinic directly.
Do you treat epilepsy in children?
Yes, Dr Bahlo’s scope includes epilepsy across age groups, including conditions that affect children, along with related developmental and neurological concerns.
What should I bring to my first consultation?
For the initial visit, bring any relevant medical records, imaging or test results, a list of current symptoms, and any questions you have about epilepsy or other neurological concerns.
How can I learn more about the specific conditions you treat?
You can discuss your concerns during a consult, or request information about particular conditions like various epilepsy syndromes, ataxias, or genetic neurological disorders that Dr Bahlo has experience with.

Contact Information

Parkville, NSW 3052, Australia

Is this your profile?

Claim this profile →

Memberships

  • the Order of Australia (AM)
  • Fellow of the Australian Academy of Health and Medical Sciences
  • Moran Medal, Australian Academy of Science
  • Ross Crozier Medal, Genetics Society of Australasia (2015)
  • Member of the board of AGRF (Australian Genome Research Facility)